Nemaura Medical Inc logo

Nemaura Medical Inc

$ 2.22 +0.17 (+8.29%) 10:08 PM EST
P/E:
At Loss
P/B:
0
Market Cap:
$ 53.51M
Enterprise V:
$ 60.19M
Volume:
10.33K
Avg Vol (2M):
12.35K
Also Trade In:
Volume:
10.33K
Market Cap $:
53.51M
PE Ratio:
At Loss
Avg Vol (2-Month):
12.35K
Enterprise Value $:
60.19M
PB Ratio:
0
GF Score:
Year:
Not Enough Data to Display
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Not Enough Data to Display
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
Nemaura Medical Inc is a medical technology company developing sugarBEAT as a non-invasive, affordable and flexible Continuous Glucose Monitor (CGM) designed for people with diabetes and pre-diabetics to manage their glucose levels. Insulin users can adjunctively use sugarBEAT when calibrated with a finger-stick glucose reading. SugarBEAT consists of a daily disposable adhesive skin-patch connected to a rechargeable transmitter with an app displaying glucose readings at five minute intervals for periods up to 24 hours.
Name Current Vs Industry Vs History
Cash-To-Debt 0.48
Equity-to-Asset -0.57
Debt-to-Equity -2.32
Debt-to-EBITDA -2.4
Piotroski F-Score 5/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -5.17
Distress
Grey
Safe
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 74.01
9-Day RSI 56.2
14-Day RSI 51.38
6-1 Month Momentum % -12.94
12-1 Month Momentum % -48.77

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.68
Quick Ratio 0.59
Cash Ratio 0.49
Days Inventory 1319.97
Days Sales Outstanding 136.91
Days Payable 150.56

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -5.1
Name Current Vs Industry Vs History
Gross Margin % 27.85
Operating Margin % -1560.73
Net Margin % -2613.49
ROA % -64.9
ROIC % -44.57
ROC (Joel Greenblatt) % -607.56
ROCE % -187.58

GF Value Rank

Name Current Vs Industry Vs History
PS Ratio 92.49
EV-to-EBIT -6.67
EV-to-EBITDA -6.92
EV-to-Revenue 104.14
EV-to-Forward-Revenue 68.43
EV-to-FCF -7.32
Earnings Yield (Greenblatt) % -14.99

Financials (Next Earnings Date:2023-02-10 Est.)

NMRD's 30-Y Financials

Guru Trades

See Details
To
Not Enough Data to Display

Insider Trades

See Details
To
Not Enough Data to Display

Gurus Latest Trades with NAS:NMRD

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
Not Enough Data to Display

Performance

Dividend
Log
To
Not Enough Data to Display

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Not Enough Data to Display

Valuation Box

Year:
Not Enough Data to Display

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0.578
EPS (TTM) ($) -0.64
Beta -0.75
Volatility % 51.1
14-Day RSI 51.38
14-Day ATR ($) 0.203387
20-Day SMA ($) 2.249435
12-1 Month Momentum % -48.77
52-Week Range ($) 1.5 - 5.94
Shares Outstanding (Mil) 24.1

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 5
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Nemaura Medical Inc Filings

Document Form Filing Date
No Filing Data

Nemaura Medical Inc Analysis

Share your research

Headlines

See More
No news.